CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2023		54,745
Beginning balance at Dec. 31, 2023	$ 40,564	$ 1	$ 2,567	$ (48)	$ 324,191	$ 20	$ (286,167)
Common stock, beginning balance (in shares) at Dec. 31, 2023			256,688,304
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense	7,427				7,427
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)			1,027,025
Issuance of common stock for stock option exercises and restricted stock unit vesting, net	(70)		$ 10		(80)
Issuance of common stock for capital raises, net (in shares)			33,773,729
Issuance of Common Stock for capital raises, net	35,737		$ 338		35,399
Series B convertible preferred stock reacquisition (in shares)		(54,745)
Series B Convertible Preferred Stock reacquisition	0	$ (1)			1
Other comprehensive income	28					28
Net loss	$ (54,054)						(54,054)
Convertible preferred stock, ending balance (in shares) at Dec. 31, 2024	0	0
Ending balance at Dec. 31, 2024	$ 29,632	$ 0	$ 2,915	(48)	366,938	48	(340,221)
Common stock, ending balance (in shares) at Dec. 31, 2024	291,367,558		291,489,058
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense	$ 7,707				7,707
Issuance of common stock for stock option exercises and restricted stock unit vesting, net (in shares)			1,012,414
Issuance of common stock for stock option exercises and restricted stock unit vesting, net	(146)		$ 10		(156)
Issuance of common stock for capital raises, net (in shares)			20,000,000
Issuance of Common Stock for capital raises, net	18,474		$ 200		18,274
Other comprehensive income	13					13
Net loss	$ (67,846)						(67,846)
Convertible preferred stock, ending balance (in shares) at Dec. 31, 2025	0	0
Ending balance at Dec. 31, 2025	$ (12,166)	$ 0	$ 3,125	$ (48)	$ 392,763	$ 61	$ (408,067)
Common stock, ending balance (in shares) at Dec. 31, 2025	312,379,972		312,501,472